We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Assays Compared For Diagnosis of Mycoplasma Infection

By LabMedica International staff writers
Posted on 23 Nov 2011
Both molecular and serological assays have been compared for detection of Mycoplasma infection in nasopharyngeal aspirates and serum samples.

Two commercial polymerase chain reaction (PCR) assays including a real-time PCR test, and an oligochromatographic test, and one serology test were compared for the ability to detect Mycoplasma pneumoniae mainly in pediatric patients.

At the Universitat Autònoma de Barcelona (Spain) a total of 145 nasopharyngeal aspirate specimens were collected from June 2008 to December 2009. More...
This included samples from pediatric patients with respiratory infection who presented at the emergency department and healthy children. Serum samples were obtained on admission, and convalescent serum samples were obtained 4–6 weeks later from all patients. Serum samples were tested on reception.

Serum samples were tested against M. pneumoniae using a commercial particle semiquantitative agglutination test kit (Serodia-Myco II test, Fujirebio; Tokyo, Japan, ). This agglutination assay uses gelatin particles sensitized with a crude antigen suspension of M. pneumoniae. The Speed-oligo M. pneumoniae test (Vircell; Granada, Spain) is a PCR-based method coupled to a dipstick device that enables a rapid detection of M. pneumoniae in clinical samples. The real-time PCR was performed with the SmartCycler II instrument (Cepheid; Sunnyvale, CA, USA).

Among the 145 samples, 32 serum pairs were serologically positive for M. pneumoniae. Of these, in 30 nasopharyngeal aspirates, M. pneumoniae was detected using the real-time PCR assay and 25 using Speed-oligo, corresponding to a sensitivity of 93.7% and 78.1%, respectively. Among the 94 samples with negative serology, only one positive result was obtained by real-time PCR assay. In the group of samples from healthy children, no positive results were obtained. M. pneumoniae is a pathogen that is a causative agent of respiratory tract infections

The authors concluded both PCR methods are fast; real-time PCR needs about one hour to complete and Speed-oligo PCR is completed within 55 minutes and detection requires no more than five minutes. However, the laboratory diagnosis of a chosen clinical episode should not rest on the PCR or acute phase serologic assay alone, but must also include antibody assays to confirm whether infection is current or represents persistence from past exposure. The study was published online on October 14, 2011, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Universitat Autònoma de Barcelona
Fujirebio
Cepheid




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.